
North America Dry Eye Syndrome Market Report, 2025-2033
Description
The North America dry eye syndrome market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.89% during 2025-2033.
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Canada
Analysis for Each Country Market by Disease Type Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Market by Drug Type Lubricant Eye Drops
Anti-inflammatory Drugs
Autologous Serum Eye Drops
Others
Market by Product Liquid Drops
Gels
Liquid Wipes
Eye Ointments
Others
Market by Distribution Channel Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Value Chain Analysis Key Drivers and Challenges Porters Five Forces Analysis Competitive Landscape Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on disease type, drug type, product and distribution channel.
- Key Regions Analysed
Canada
Aqueous Dry Eye Syndrome
Anti-inflammatory Drugs
Autologous Serum Eye Drops
Others
Gels
Liquid Wipes
Eye Ointments
Others
Hospital Pharmacies
Online Pharmacies
Key Player Profiles
Key Questions Answered in This Report:
- How has the North America dry eye syndrome market performed so far and how will it perform in the coming years?
- What are the key regions in the North America dry eye syndrome market?
- What has been the impact of COVID-19 on the North America dry eye syndrome market?
- What is the breakup of the North America dry eye syndrome market on the basis of disease type?
- What is the breakup of the North America dry eye syndrome market on the basis of drug type?
- What is the breakup of the North America dry eye syndrome market on the basis of product?
- What is the breakup of the North America dry eye syndrome market on the basis of distribution channel?
- What are the various stages in the value chain of the North America dry eye syndrome industry?
- What are the key driving factors and challenges in the North America dry eye syndrome industry?
- What is the structure of the North America dry eye syndrome industry and who are the key players?
- What is the degree of competition in the North America dry eye syndrome industry?
- What are the profit margins in the North America dry eye syndrome industry?
Table of Contents
120 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Dry Eye Syndrome Market
- 5.1 Market Performance
- 5.2 Market Breakup by Disease Type
- 5.3 Market Breakup by Drug Type
- 5.4 Market Breakup by Product
- 5.5 Market Breakup by Distribution Channel
- 5.6 Market Breakup by Region
- 5.7 Market Forecast
- 6 North America Dry Eye Syndrome Market
- 6.1 Market Performance
- 6.2 Impact of COVID-19
- 6.3 Market Forecast
- 7 North America Dry Eye Syndrome Market: Breakup by Disease Type
- 7.1 Evaporative Dry Eye Syndrome
- 7.2 Aqueous Dry Eye Syndrome
- 8 North America Dry Eye Syndrome Market: Breakup by Drug Type
- 8.1 Lubricant Eye Drops
- 8.2 Anti-inflammatory Drugs
- 8.3 Autologous Serum Eye Drops
- 8.4 Others
- 9 North America Dry Eye Syndrome Market: Breakup by Product
- 9.1 Liquid Drops
- 9.2 Gels
- 9.3 Liquid Wipes
- 9.4 Eye Ointments
- 9.5 Others
- 10 North America Dry Eye Syndrome Market: Breakup by Distribution Channel
- 10.1 Retail Pharmacies
- 10.2 Hospital Pharmacies
- 10.3 Online Pharmacies
- 11 North America Dry Eye Syndrome Market: Breakup by Country
- 11.1 United States
- 11.1.1 Historical Market Trends
- 11.1.2 Market Breakup by Disease Type
- 11.1.3 Market Breakup by Drug Type
- 11.1.4 Market Breakup by Product
- 11.1.5 Market Breakup by Distribution Channel
- 11.1.6 Market Forecast
- 11.2 Canada
- 11.2.1 Historical Market Trends
- 11.2.2 Market Breakup by Disease Type
- 11.2.3 Market Breakup by Drug Type
- 11.2.4 Market Breakup by Product
- 11.2.5 Market Breakup by Distribution Channel
- 11.2.6 Market Forecast
- 12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
- 13 Value Chain Analysis
- 14 Porter’s Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Rivalry
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
- 15 Price Analysis
- 16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.